Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Special Voting Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total Stockholder's Equity
Noncontrolling Interest in Consolidated Subsidiary
Balance at Jun. 30, 2019 $ 18,717,734 $ 1,059 $ 46,299,233 $ (27,582,558) $ 18,717,734
Balance, shares at Jun. 30, 2019   10,589,746          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon warrant exercise 4,247,065 $ 37 4,247,028 4,247,065
Common stock issued upon warrant exercise, shares   369,311          
Non-controlling interest in acquired subsidiary 5,554,011 5,554,011
Stock-based compensation amortization 1,253,234 1,253,234 1,253,234
Forfeitures of restricted shares $ (5) 5
Forfeitures of restricted shares, shares   (54,901)          
Change in fair value of Convertible Notes 63,000 63,000 63,000
Special voting preferred stock issued in business combination              
Conversion of exchangable shares to common, shares            
Settlement of convertible debt, shares            
Common stock issued in business combinations 20,081,466 $ 230 20,081,236 20,081,466
Common stock issued in business combinations, shares   2,299,650          
Warrant Adjustment 21,738 21,738 21,738
Net loss (14,422,070) (13,572,311) (13,572,311) (849,759)
Balance at Jun. 30, 2020 35,516,178 $ 1,321 71,902,474 63,000 (41,154,869) 30,811,926 4,704,252
Balance, shares at Jun. 30, 2020   13,203,806          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation amortization 1,298,540 1,298,540 1,298,540
Foreign currency translation adjustments (21,497) (21,497) (21,497)
Special voting preferred stock issued in business combination 25,203,490 $ 25,203,490 25,203,490
Special voting preferred stock issued in business combination, shares   3,294,574          
Issuance of common stock 11,032,380 $ 500 11,031,880 11,032,380
Issuance of common stock, shares   5,000,000          
Conversion of exchangable shares to common $ (4,798,271) $ 63 4,798,208
Conversion of exchangable shares to common, shares   (627,225) 627,225          
Acquisition of noncontrolling interests $ 80 4,695,357 4,695,437 (4,695,437)
Balance as of July 1, 2020 35,702,003 1,321 71,902,474 63,000 (40,969,044) 30,997,751 4,704,252
Adoption of ASC 606 Adjustment 185,825 185,825 185,825
Balance as of July 1, 2020, shares   13,203,806          
Acquisition of noncontrolling interest, shares   800,000          
Settlement of convertible debt 360,000 $ 11 359,989 360,000
Settlement of convertible debt, shares   112,867          
Restricted stock unit vesting $ 15 (15)
Restricted stock unit vesting, shares   157,350          
Unrealized loss (gains) on Convertible Notes (133,000) (133,000) (133,000)
Net loss (16,219,296) (16,210,481) (16,210,481) (8,815)
Balance at Dec. 31, 2020 57,222,620 $ 20,405,219 $ 1,990 94,086,433 (91,497) (57,179,525) 57,222,620
Balance, shares at Dec. 31, 2020   2,667,349 19,901,248          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation amortization 2,070,358 2,070,358 2,070,358
Forfeitures of restricted shares
Forfeitures of restricted shares, shares   (1,336)          
Foreign currency translation adjustments 53,020 53,020 53,020
Special voting preferred stock issued in business combination              
Issuance of common stock $ 1,900,000              
Issuance of common stock, shares 556,388              
Conversion of exchangable shares to common $ (18,039,181) $ 237 18,038,944
Conversion of exchangable shares to common, shares   (2,358,063) 2,358,063          
Settlement of convertible debt 11,610,586 $ 309 11,610,277 11,610,586
Settlement of convertible debt, shares   3,094,129          
Restricted stock unit vesting $ 42 (42)
Restricted stock unit vesting, shares   427,711          
Unrealized loss (gains) on Convertible Notes 100,000 100,000 100,000
Settlement of liabilities with shares 430,025 $ 10 430,015 430,025
Settlement of liabilities with shares, shares   101,705          
Shares issued in connection with Asset Purchase 300,000 $ 8 299,992 300,000
Shares issued in connection with Asset Purchase, shares   83,333          
Shares issued in connection with 365 Cannabis Acquisition 11,996,061 $ 357 11,995,704 11,996,061
Shares issued in connection with 365 Cannabis Acquisition shares   3,571,429          
Shares issued in connection with the ATM program 1,828,119 $ 56 1,828,063 1,828,119
Shares issued in connection with Viridian Acquisition 6,188,000 $ 103 6,187,897 6,188,000
Shares issued in connection with viridian acquisition, Shares   1,031,000          
Shares withheld for withholding taxes 520,395 $ 12 520,383 520,395
Shares withheld for withholding taxes, shares   (121,786)          
Net loss (31,328,711)   (31,328,711) (31,328,711)
Balance at Dec. 31, 2021 $ 59,949,683 $ 2,366,038 $ 3,100 $ 146,027,258 $ 61,523 $ 88,508,236 $ 59,949,683
Balance, shares at Dec. 31, 2021   309,286 31,001,884          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued in connection with the ATM program, share   556,388